FDA Approves Roche’s Monoclonal Antibody Drug For COVID-19 Treatment In Hospitalized Adult Patients

Reuters (12/21, Mahobe) reports, “Roche Holding AG said on Wednesday the U.S. Food and Drug Administration (FDA) had approved its monoclonal antibody for treating COVID-19 in hospitalized adult patients.” The “intravenous anti-inflammatory drug,” tocilizu...